Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 451 JPY 0.48% Market Closed
Market Cap: 496.3B JPY

Intrinsic Value

The intrinsic value of one Santen Pharmaceutical Co Ltd stock under the Base Case scenario is 2 147.18 JPY. Compared to the current market price of 1 451 JPY, Santen Pharmaceutical Co Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 147.18 JPY
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Santen Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Santen Pharmaceutical Co Ltd
TSE:4536
JP
Pharmaceuticals
Market Cap
495.3B JPY
IPO
Nov 4, 1963
JP
Pharmaceuticals
Market Cap
495.3B JPY
IPO
Nov 4, 1963
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Santen Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Santen Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Santen Pharmaceutical Co Ltd

Current Assets 205.1B
Cash & Short-Term Investments 78.7B
Receivables 69.3B
Other Current Assets 57.2B
Non-Current Assets 193.2B
Long-Term Investments 20.2B
PP&E 74.4B
Intangibles 79.6B
Other Non-Current Assets 19B
Efficiency

Free Cash Flow Analysis
Santen Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Santen Pharmaceutical Co Ltd

Revenue
301.9B JPY
Cost of Revenue
-129.3B JPY
Gross Profit
172.6B JPY
Operating Expenses
-135B JPY
Operating Income
37.6B JPY
Other Expenses
-10.1B JPY
Net Income
27.5B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Santen Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

55/100
Profitability
Score

Santen Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Santen Pharmaceutical Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
91/100
Solvency
Score

Santen Pharmaceutical Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Santen Pharmaceutical Co Ltd

Wall Street analysts forecast Santen Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 061.53 JPY with a low forecast of 1 717 JPY and a high forecast of 2 625 JPY.

Lowest
Price Target
1 717 JPY
18% Upside
Average
Price Target
2 061.53 JPY
42% Upside
Highest
Price Target
2 625 JPY
81% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Santen Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Santen Pharmaceutical Co Ltd stock?

The intrinsic value of one Santen Pharmaceutical Co Ltd stock under the Base Case scenario is 2 147.18 JPY.

Is Santen Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 451 JPY, Santen Pharmaceutical Co Ltd is Undervalued by 32%.

Back to Top